Optimising patient safety in paediatric prescription

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006792

Enrollment

625

Registered

2014-10-01

Start date

2011-08-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases in children and adolescents

Interventions

Group 1: Dosage recommendations and individualised pharmaceutical counselling on drug-related problems in prescription (especially concerning inhalative drugs and antipyretics/analgesics). Group 2: A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All consecutive prescriptions of hospitalised patients at our department for children and adolescents

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Number of patients with a least one pre-defined drug-related problem in prescription	—

Secondary

Measure	Time frame
Not specified	—

Countries

Germany

Contacts

Public ContactThilo Bertsche

Klinische PharmazieInstitut für PharmazieUniversität Leipzig

thilo.bertsche@medizin.uni-leipzig.de03419736600

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 5, 2026